Navigation Links
Polymedco Announces Publication in Epidemiologic Reviews
Date:8/17/2011

CORTLANDT MANOR, N.Y., Aug. 17, 2011 /PRNewswire/ -- Polymedco is pleased to announce a publication in Epidemiologic Review, "Organized Colorectal Cancer Screening in Integrated Health Care Systems" by Theodore R Levin, Laura Jamieson, Daniel A Burley, Juan Reyes, Michael Oehrli, and Cindy Caldwell (Epidemiol Rev (2011)33(1);101-110).  The publication details the organized screening program for Colorectal cancer (CRC) at Kaiser Permanente Northern California (KPNC).   The CRC screening program at KPNC was introduced in the 1960's with sigmoidoscopy.  FIT (fecal immunochemical test) was introduced in 2004.  FIT is now the screening test of choice for CRC screening in this organized outreach and inreach program.  The HEDIS score for 2007 of 50% for commercial patients jumped dramatically to 69% in 2010.  The HEDIS score for 2007 of 50% for Medicare patients jumped to an incredible 78% in 2010.  From 2007 to 2009, nearly 200 additional localized cancers were detected annually. The advantages of FIT over the traditional Fecal Occult blood Guaiac test are as follows:  improved patient acceptance so patients adhere to screening which is in part due to the improved collection device, fewer samples collected and no dietary restrictions, and improved specificity; not affected by anticoagulant or non steroidal medications.  Automated specimen processing offers improved test reliability with no subjectivity, consistent reliable positivity of the test results from week to week, and quality assurance to monitor the standards and quality control.  

Polymedco Inc. is a leading manufacturer, marketer, and distributer in the clinical laboratory marketplace.  Polymedco supplies clinical diagnostic test kits and devices that are specialized in hematology and cancer. We are a world leader in non-invasive colorectal cancer screening technology, providing the new standard of care with the OC FIT-CHEK® product line.

Since 1980, Polymedco has evolved into a highly skilled and successful marketing, sales, and manufacturing organization. With an experienced team of field representatives combined with strong technical service personnel, Polymedco provides a high level of customer, technical and reimbursement support.


'/>"/>
SOURCE Polymedco
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ConvaTec Announces Asia-Pacific Leadership Appointments
2. Fuisz Pharma Announces Publication of US Patent Pending for a System That Confirms Drug Compliance
3. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
4. Concord Medical Announces Higher Revenues, Net income, and Earnings per ADS for the Second Quarter 2011
5. Beacon Enterprise Solutions Announces $3.4 Million Contract Award With the Veterans Administration
6. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
7. 3SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results
8. NewCardio Announces Financial Results for Its 2011 Second Quarter
9. Dehaier Medical Announces Record Second Quarter 2011 Financial Results
10. Emdeon Announces Support for Electronic Prescribing of Controlled Substances Using the DEA-Allowed Quicker-to-Market Approach
11. Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Feb. 22, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE ... the quarter and full fiscal year ended December 31, 2016. ... ... Company,s audited financial statements and management discussion and analysis for ... been filed on SEDAR and are available at www.sedar.com ...
(Date:2/22/2017)... Feb. 22, 2017 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... its Fourth Quarter 2016 investor conference call and webcast at ... The call will cover an update on Merrimack,s recent ... full year 2016 financial results. A press release detailing the ... the morning of Wednesday, March 1. Investors and the general ...
(Date:2/22/2017)... NEW YORK , Feb. 22, 2017 ... non-small cell lung cancer partnering deals and agreements entered ... the full report: http://www.reportlinker.com/p03605668-summary/view-report.html Description The ... since 2010 report provides understanding and access to partnering ... healthcare companies. - Trends in partnering deals ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... , ... The Waismann Method® is providing a faster, safer, and ... victim to America’s opioid epidemic. Now, opiate dependent individuals can be treated in a ... the shame, stigma, and harmful labeling believed to prevent many of these ...
(Date:2/22/2017)... ... February 22, 2017 , ... VitreosHealth ... each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as gaps-in-care ... transform the HCC Risk Adjustment process from a typical fragmented process to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, the ... featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” ... neurosurgeons in Michigan performing minimally invasive back surgery that often results in less ...
(Date:2/22/2017)... ... February 22, 2017 , ... The SeniorCare Investor will host an important webinar— ... 23, 2017, at 1:00 PM ET. A recording of the webinar will also be ... Series. , If you want to find out what really happened in the seniors ...
Breaking Medicine News(10 mins):